News & Updates
Filter by Specialty:
Empagliflozin beneficial and well tolerated in acute heart failure
Empagliflozin provides a significant clinical benefit within 90 days and shows no safety concerns in patients hospitalized for acute heart failure (HF), according to results of the EMPULSE trial reported at the American Heart Association (AHA) Scientific Sessions 2021.
Empagliflozin beneficial and well tolerated in acute heart failure
06 Dec 2021E-cigarettes raise risk of erectile dysfunction
Electronic nicotine delivery devices (ENDS) or e-cigarettes appear to be detrimental to men, with a recent study suggesting that its use contributes to a heightened risk of erectile dysfunction.
E-cigarettes raise risk of erectile dysfunction
05 Dec 2021Daily iron, folic acid supplementation alleviates anaemia in adolescent girls
Ninety-day supplementation of iron and folic acid (IFA) with or without vitamin B12 results in a reduction in iron and vitamin B12 deficiency and a decrease in the overall proportion of anaemia, reveals a study in India. However, adding vitamin B12 to IFA supplementation does not contribute to the improvement of haemoglobin levels among adolescent girls.